Haleos Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2026 ,inter alia, to consider and approve the unaudited financial results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2026 and any other item as may be decided by the Board of Directors.

November 7,2026 BSE Limited, National Stock Exchange of India Limited, Listing Department, P J Towers, Listing Department, "Exchange Plaza", Dalal street, Bandra·Kurla complex, Bandra (E), Mumbai - 400 001. Mumbal . 400 051. scrip Code: 540679 Trading Symbol: HALEOSLABS SUB: INTIMATION OF THE 99TH BOARD MEETING. Ref: Reg. 29 and 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. Dear Sir/Madam, We would like to inform you that the 99th meeting of the Board of Directors of the Company has been scheduled to be held on Wednesday, November 11, 2026, inter alia, to consider the following: unaudited financial results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2026, .. any other item as may be decided by the Board of Directors. The trading window for dealing in the securities of the Company shall remain closed for all the Designated Persons and their Immediate Relatives pursuant to Clause 4 of Schedule B of the SEBI (Prohibition of Insider Trading) Regulations, 2015 till November13, 2026. Please take the same on record and suitably disseminate it to all concerned. For Haleos Labs Limited company Secretary Haleos Labs Limited (Formerly SMS lifesciences India limited) Registered & Corporate Offlca: Plot No. 19-111, Road No. 71, Opp. Bharatiya Vidya Shavan Public School, Jubilee Hills, Hyderabad -500 096, Telangana, India. Tel: +91-40-6628 88881 CIN -L74930TG2006PLC050223I info@haleoslabs.com I www.haleoslabs.com